Rapid-acting (mealtime) insulin on Blue Cross MedicareRx Basic (S5715-014)
Humalog, Novolog and the other mealtime insulins, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Texas
- Premium
- $104.70/month
- Deductible
- $615.00
4 of 7 Rapid-acting insulin are covered on this plan. None require prior authorization.
3 aren't on the formulary, including insulin lispro and Admelog.
- from $118.36Tier 3
- from $125.02Tier 3
- from $79.31Tier 3
- from $79.31Tier 3
Not on the formulary
insulin lispro, Admelog, Apidra
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.